| Hazard Information | Back Directory | [Uses]
Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases. | [in vivo]
Ozoralizumab (ATN-103; 1 mg/kg; s.c.; Tg197 human TNF transgenic mice) inhibits arthritis and reduces arthritis scores[1]. | Animal Model: | Tg197 human TNF transgenic mice[1] | | Dosage: | 1 mg/kg | | Administration: | Subcutaneous injection | | Result: | Reduced the mean histopathologic score in the Tg197 mice.
Had ability to neutralize TNFα activity.
|
|
|
| Company Name: |
Biolab Reagents
|
| Tel: |
18108604356 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|